Boston University Office of Research reposted this
Antimicrobial resistance is a global threat, and our response must be equally global. Advancing the next generation of life-saving antibacterial products requires sustained investment and collaboration across borders. CARB-X creates opportunities for those partnerships and investments to take shape, which is a critical part of accelerating innovation. We convened product developers, funders, and industry leaders in Munich for CARB-X's fourth annual Investor Day to showcase innovative antibacterial programs, discuss opportunities for partnership, and foster global connections among the people working to develop AMR solutions. Watch the video to learn about the value this collaborative meeting delivers from CARB-X Executive Director Kevin Outterson, EU in Emergencies Acting Head of Unit Ana Burgos Gutierrez, Novo Nordisk Foundation Head of Infectious Diseases Marianne H., and Global Antibiotic R&D Partnership (GARDP) R&D Director Seamus O'Brien. Video by Kalory | Photo & Video | #AMR #StopSuperbugs #AntibioticResistance #Medicine #GlobalHealth #ProductDevelopment #Innovation #Biotechnology Boston University Office of Research Boston University Biomedical Advanced Research and Development Authority (BARDA) Wellcome Trust Bundesministerium für Bildung und Forschung Gates Foundation Government of Canada Novo Nordisk Foundation Ministero dell'economia e delle finanze EU in Emergencies KfW